JPH0256489A - セフアロスポリン誘導体の製法 - Google Patents

セフアロスポリン誘導体の製法

Info

Publication number
JPH0256489A
JPH0256489A JP1112311A JP11231189A JPH0256489A JP H0256489 A JPH0256489 A JP H0256489A JP 1112311 A JP1112311 A JP 1112311A JP 11231189 A JP11231189 A JP 11231189A JP H0256489 A JPH0256489 A JP H0256489A
Authority
JP
Japan
Prior art keywords
compound
compd
formula
agent
oximizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1112311A
Other languages
English (en)
Japanese (ja)
Inventor
Michael George Grey
マイクル・ジヨージ・グレイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPH0256489A publication Critical patent/JPH0256489A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP1112311A 1988-05-03 1989-05-02 セフアロスポリン誘導体の製法 Pending JPH0256489A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888810393A GB8810393D0 (en) 1988-05-03 1988-05-03 Chemical process
GB8810393.2 1988-05-03

Publications (1)

Publication Number Publication Date
JPH0256489A true JPH0256489A (ja) 1990-02-26

Family

ID=10636246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1112311A Pending JPH0256489A (ja) 1988-05-03 1989-05-02 セフアロスポリン誘導体の製法

Country Status (8)

Country Link
JP (1) JPH0256489A (it)
KR (1) KR970001530B1 (it)
CH (1) CH678624A5 (it)
DE (1) DE3914672A1 (it)
FR (1) FR2631032A1 (it)
GB (2) GB8810393D0 (it)
IT (1) IT1232829B (it)
NL (1) NL8901110A (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1208014A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
FR2631032A1 (fr) 1989-11-10
GB8810393D0 (en) 1988-06-08
IT8947903A0 (it) 1989-05-02
GB2218092A (en) 1989-11-08
DE3914672A1 (de) 1989-11-16
GB8909986D0 (en) 1989-06-21
KR970001530B1 (ko) 1997-02-11
NL8901110A (nl) 1989-12-01
KR890017255A (ko) 1989-12-15
CH678624A5 (it) 1991-10-15
IT1232829B (it) 1992-03-05

Similar Documents

Publication Publication Date Title
JPH0320397B2 (it)
US5081116A (en) Cephalosporin derivatives
NO147916B (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
US4496562A (en) 7-Substituted-3-cephem-4-carboxylic acid esters
JPS6052711B2 (ja) セフアロスポリン化合物の製法
EP0018546B1 (en) Process for the production of phenylglycyl chloride hydrochlorides
US4935508A (en) Process for cephem prodrug esters
JP3121903B2 (ja) デアセチルセファロスポラン酸のカルバモイル化方法
JPH0256489A (ja) セフアロスポリン誘導体の製法
US3928333A (en) Process for the preparation of 3 cephalosporin esters
JPS6135199B2 (it)
DE2619243C2 (de) Verfahren zur Herstellung von 3-Acyloxymethyl-cephem-Verbindungen
JPH021835B2 (it)
JP2595605B2 (ja) 2−置換オキシイミノ−3−オキソ酪酸の製造法
KR970001531B1 (ko) 화합물의 제조 방법
GB2218095A (en) Cepholosporin isomerisation
CA1097652A (en) Eprimerization process
JPS6117587A (ja) セフアロスポリン化合物の製造方法
FI89926C (fi) Process foer framstaellning av cefalosporinfoereningar
JP2669955B2 (ja) アゼチジノン誘導体及びその製造法
GB2218091A (en) Cephalosporin methylation
EP0638574A1 (en) Oxime derivatives of cephalosporanic structure and compounds for their preparation
JPH0653747B2 (ja) セフアロスポリン化合物の製法
JPH04112891A (ja) 新規オキシム誘導体及び該誘導体を含有する抗菌剤
JPS643197B2 (it)